Catalyst Biosciences Inc (CBIO.OQ)
CBIO.OQ on NASDAQ Stock Exchange Capital Market
6.92USD
16 Aug 2019
6.92USD
16 Aug 2019
Change (% chg)
$-0.15 (-2.12%)
$-0.15 (-2.12%)
Prev Close
$7.07
$7.07
Open
$7.05
$7.05
Day's High
$7.11
$7.11
Day's Low
$6.86
$6.86
Volume
19,072
19,072
Avg. Vol
51,176
51,176
52-wk High
$11.44
$11.44
52-wk Low
$6.20
$6.20
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Jun '19 | 0.00 | -1.149 |
| Mar '19 | 0.00 | -1.261 | |
| FY 2018 | Dec '18 | 0.00 | -0.907 |
| Sep '18 | 0.00 | -0.644 | |
| Jun '18 | 0.00 | -0.543 | |
| Mar '18 | 0.01 | -0.561 | |
| FY 2017 | Dec '17 | 0.32 | -1.261 |
| Sep '17 | 0.32 | -1.344 | |
| Jun '17 | 0.11 | -2.534 | |
| Mar '17 | 0.27 | -4.567 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 3 | 0.30 | 0.90 | 0.00 | 0.00 |
| Quarter Ending Dec-19 | 3 | 0.00 | 0.00 | 0.00 | 0.30 |
| Year Ending Dec-19 | 3 | 0.30 | 0.90 | 0.00 | 0.53 |
| Year Ending Dec-20 | 3 | 0.48 | 1.45 | 0.00 | 19.03 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 3 | -1.08 | -0.93 | -1.19 | -0.77 |
| Quarter Ending Dec-19 | 3 | -1.04 | -0.83 | -1.23 | -0.88 |
| Year Ending Dec-19 | 3 | -4.47 | -4.01 | -4.83 | -3.36 |
| Year Ending Dec-20 | 3 | -4.23 | -3.62 | -4.54 | -2.46 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 29.89 | 32.67 | |
| P/E High - Last 5 Yrs. | -- | 42.97 | 47.29 | |
| P/E Low - Last 5 Yrs. | -- | 23.36 | 23.87 | |
| Beta | 1.35 | 0.89 | 0.89 | |
| Price to Sales (TTM) | 43.72 | 6.25 | 7.91 | |
| Price to Book (MRQ) | 0.81 | 5.26 | 5.38 | |
| Price to Tangible Book (MRQ) | 0.81 | 5.93 | 6.71 | |
| Price to Cash Flow (TTM) | -- | 23.51 | 24.37 | |
| % Owned Institutions | 33.39 | 0.75 | 1.45 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.42 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 1.44 | 1.38 | |
| Dividend 5 Year Growth Rate | -- | 3.90 | 4.54 | |
| Payout Ratio(TTM) | -- | 42.60 | 40.24 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 1.83 | 5.12 | 12.23 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 28.90 | 6.49 | 7.74 | |
| Sales - 5 Yr. Growth Rate | -66.71 | 10.59 | 10.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 59.98 | 40.63 | 42.99 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 43.85 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.78 | 10.32 | |
| Capital Spending - 5 Yr. Growth Rate | -20.03 | 15.44 | 14.84 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.11 | 2.21 |
| Current Ratio (MRQ) | 4.23 | 2.93 | 3.03 |
| LT Debt to Equity (MRQ) | 0.00 | 7.95 | 10.20 |
| Total Debt to Equity (MRQ) | 19.01 | 11.64 | 14.55 |
| Interest Coverage (TTM) | -32.83 | 33.56 | 29.80 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 51.87 | 52.25 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.68 | 50.41 | |
| EBITD Margin (TTM) | -3,698.75 | -- | -- | |
| EBITD - 5 Yr. Avg | -82.54 | 17.37 | 13.13 | |
| Operating Margin (TTM) | -3,745.02 | 13.83 | 6.92 | |
| Operating Margin - 5 Yr. Avg. | -96.22 | 13.93 | 8.94 | |
| Pre-Tax Margin (TTM) | -3,298.22 | 12.46 | 6.13 | |
| Pre-Tax Margin - 5 Yr. Avg. | -88.84 | 14.33 | 9.23 | |
| Net Profit Margin (TTM) | -3,298.22 | 9.25 | 2.76 | |
| Net Profit Margin - 5 Yr. Avg. | -88.67 | 10.77 | 5.60 | |
| Effective Tax Rate (TTM) | -- | 22.43 | 22.40 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.49 | 22.74 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 56,200 | 992,940,732 | 887,145,970 | |
| Net Income/Employee (TTM) | -1,853,600 | 114,013,845 | 101,828,577 | |
| Receivable Turnover (TTM) | 1.88 | 5.96 | 5.93 | |
| Inventory Turnover (TTM) | -- | 2.62 | 3.36 | |
| Asset Turnover (TTM) | 0.01 | 0.97 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -38.28 | 11.51 | 11.17 | |
| Return on Assets - 5 Yr. Avg. | -9.94 | 12.96 | 12.34 | |
| Return on Investment (TTM) | -68.74 | 14.89 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -12.47 | 16.86 | 16.02 | |
| Return on Equity (TTM) | -83.55 | 16.01 | 15.78 | |
| Return on Equity - 5 Yr. Avg. | -16.87 | 17.66 | 17.01 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -77.20 | -8.63 | -66.71 |
| EPS (TTM) % | 56.50 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Catalyst Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 61.02 | 55.47 | 99 | 24 |
| 13 Week | 23.64 | 17.62 | 87 | 42 |
| 26 Week | 4.59 | -3.36 | 62 | 42 |
| 52 Week | -67.80 | -72.70 | 4 | 12 |
| YTD | -41.55 | -48.67 | 10 | 38 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 79.28% |
| # of Holders: | 79 |
| Total Shares Held: | 9,526,124 |
| 3 Mo. Net Change: | 62,941 |
| # New Positions: | 12 |
| # Closed Positions: | 28 |
| # Increased Positions: | 36 |
| # Reduced Positions: | 52 |
| # Net Buyers: | -16 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.